☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Kashiv Biosciences
Kashiv BioSciences Partners with Amneal Pharmaceuticals to Commercialize ADL018 (Biosimilar, Xolair)
July 2, 2024
Kashiv BioSciences Reports the First Patient Enrolment of ADL018 (biosimilar, omalizumab) in the P-III Clinical Study for Chronic...
October 3, 2023
Kashiv Biosciences Reports P-I Clinical Study Results of ADL018 (biosimilar, omalizumab)
July 5, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.